FDA Approved: ENOXAPARIN SODIUM — Original Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved BluePoint Laboratories' original ANDA for enoxaparin sodium, a low molecular weight heparin, expanding availability of its approved prophylaxis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Non-st-elevation Myocardial Infarction
• Pulmonary Embolism
• Unstable Angina

Drugs mentioned

• Enoxaparin sodium (Enoxaparin sodium)

Snippet

ORIG AP for ENOXAPARIN SODIUM (ENOXAPARIN SODIUM)